标题
Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review
作者
关键词
Triple negative breast cancer, Phosphatidylinositol 3-kinase, Metabolism, Glycolysis, Oxidative stress, Apoptosis
出版物
Cancer Cell International
Volume 15, Issue 1, Pages 1
出版商
Springer Nature
发表日期
2015-01-24
DOI
10.1186/s12935-015-0156-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MicroRNAs as regulatory elements in triple negative breast cancer
- (2014) Melina-Theoni Gyparaki et al. CANCER LETTERS
- Downregulation of FOXO3a Promotes Tumor Metastasis and Is Associated with Metastasis-Free Survival of Patients with Clear Cell Renal Cell Carcinoma
- (2014) D. Ni et al. CLINICAL CANCER RESEARCH
- Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT
- (2014) N. A. O'Brien et al. CLINICAL CANCER RESEARCH
- Antitumoral Activity of Indole-3-carbinol Cyclic tri- and Tetrameric Derivatives Mixture in Human Breast Cancer Cells: In Vitro and In Vivo Studies
- (2013) Giorgio Brandi et al. Anti-Cancer Agents in Medicinal Chemistry
- Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
- (2013) Marcelo Madeira et al. BMC CANCER
- FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma
- (2013) E. E. Santo et al. CANCER RESEARCH
- The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness
- (2013) Diego Sisci et al. CELL CYCLE
- Molecular Pathways: PI3K Pathway Targets in Triple-Negative Breast Cancers
- (2013) V. Gordon et al. CLINICAL CANCER RESEARCH
- Foxo3a Expression Is a Prognostic Marker in Breast Cancer
- (2013) Ying Jiang et al. PLoS One
- Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients
- (2013) Xiao-bo Yang et al. PLoS One
- Adaptation and learning of molecular networks as a description of cancer development at the systems-level: Potential use in anti-cancer therapies
- (2013) Dávid M. Gyurkó et al. SEMINARS IN CANCER BIOLOGY
- Inhibition of metadherin sensitizes breast cancer cells to AZD6244
- (2012) Xiaoli Kong et al. CANCER BIOLOGY & THERAPY
- Arsenic Trioxide-Induced Growth Arrest of Breast Cancer MCF-7 Cells Involving FOXO3a and IκB Kinase β Expression and Localization
- (2012) Wenlou Liu et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Mutant p53 drives invasion in breast tumors through up-regulation of miR-155
- (2012) P M Neilsen et al. ONCOGENE
- An Aqueous Extract of Fagonia cretica Induces DNA Damage, Cell Cycle Arrest and Apoptosis in Breast Cancer Cells via FOXO3a and p53 Expression
- (2012) Matt Lam et al. PLoS One
- Upregulator of Cell Proliferation Predicts Poor Prognosis in Hepatocellular Carcinoma and Contributes to Hepatocarcinogenesis by Downregulating FOXO3a
- (2012) Chan Xie et al. PLoS One
- Bimodal regulation of FoxO3 by AKT and 14-3-3
- (2011) Melissa Dobson et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression
- (2011) E C Ferber et al. CELL DEATH AND DIFFERENTIATION
- Knockdown of FLOT1 Impairs Cell Proliferation and Tumorigenicity in Breast Cancer through Upregulation of FOXO3a
- (2011) C. Lin et al. CLINICAL CANCER RESEARCH
- 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells
- (2011) Gunjan Sharma et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CCN1, a Candidate Target for Zoledronic Acid Treatment in Breast Cancer
- (2011) I. Espinoza et al. MOLECULAR CANCER THERAPEUTICS
- FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
- (2011) C T Karadedou et al. ONCOGENE
- Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors
- (2011) A. Chakrabarty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway
- (2010) Gui'e Xie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of FOXO3a Is Sufficient to Reverse Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor Chemoresistance in Human Cancer
- (2010) Jer-Yen Yang et al. CANCER RESEARCH
- The AMPK-FoxO3A axis as a target for cancer treatment
- (2010) Fulvio Chiacchiera et al. CELL CYCLE
- Cost-Effectiveness of Zoledronic Acid Plus Endocrine Therapy in Premenopausal Women With Hormone-Responsive Early Breast Cancer
- (2010) Thomas E. Delea et al. Clinical Breast Cancer
- MicroRNA-155Regulates Cell Survival, Growth, and Chemosensitivity by TargetingFOXO3ain Breast Cancer
- (2010) William Kong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autophagy and the Integrated Stress Response
- (2010) Guido Kroemer et al. MOLECULAR CELL
- Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a
- (2010) Huanxin Lin et al. PLoS One
- Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
- (2009) U. B. McGovern et al. MOLECULAR CANCER THERAPEUTICS
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- Withaferin A Causes FOXO3a- and Bim-Dependent Apoptosis and Inhibits Growth of Human Breast Cancer Cells In vivo
- (2008) S. D. Stan et al. CANCER RESEARCH
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
- (2008) Jer-Yen Yang et al. NATURE CELL BIOLOGY
- PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a)
- (2008) B. M. Emerling et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now